Table 3.

Overview of patients with idiopathic T cell lymphopenia identified from TREC-based NBS

IDReferralT cells, per µl blood (% naive)aGenetic testing performedInfectionsProphylactic treatmentOther comorbidityFollow-up timebFollow-up ongoing
ITCL-1 Non-urgent (pilot) CD3+: 980
CD4+: 680 (82.1%)
CD8+: 310 (98.3%) 
WES with SCID and PID gene panel filter Viral upper respiratory tract Antibacterial (for 2.2 years after referral) No >5.5 years Yes 
ITCL-2 Non-urgent (pilot) CD3+: 1,260
CD4+: 910 (ND)
CD8+: 350 (ND) 
WES with SCID gene panel filter No No No 1 year No 
ITCL-3 Non-urgent (pilot) CD3+: 1,020
CD4+: 590 (ND)
CD8+: 450 (ND) 
WES with SCID gene panel filter No No No 1 year No 
ITCL-4 Non-urgent (pilot) CD3+: 1160
CD4+: 830 (84.6%)
CD8+: 330 (98.1%) 
WES with SCID gene panel filter No No No 7 mo No 
ITCL-5 Non-urgent (pilot) CD3+: 1,350
CD4+: 780 (81.7%)
CD8+: 530 (97.9%) 
WES with SCID and PID gene panel filter No No Extreme prematurity (<28 wk) 1.5 years No 
ITCL-6 Non-urgent CD3+: 630
CD4+: 430 (70.2%)
CD8+: 140 (67.1%) 
WES with SCID gene panel filter Viral upper respiratory tract and recurrent otitis No No >3.5 years Yes 
ITCL-7 Non-urgent CD3+: 1,410
CD4+: 1,260 (80.8%)
CD8+: 150 (96%) 
WES with SCID and PID gene panel filter, SNP array, and WGS No Antibacterial (for 6 mo after referral), antifungal (for 2 mo after referral) Okur-Chung syndrome >2.5 years No 
ITCL-8 Non-urgent CD3+: 932
CD4+: 618 (59.2%)
CD8+: 213 (81.7%) 
WES with PID gene panel filter No No No >3.25 years No 
ITCL-9 Urgent CD3+: 850
CD4+: 620 (80.6%)
CD8+: 210 (63.8%) 
WES with SCID and PID gene panel filter and SNP array No Antibacterial (started 1 month after referral, still ongoing) No >2 years Yes 
ITCL-10 Non-urgent CD3+: 1,212
CD4+: 876 (59.8%)
CD8+: 312 (94.2%) 
WES with PID gene panel filter No No Hiatal hernia 2 years No 
ITCL-11 Non-urgent CD3+: 1,262
CD4+: 933 (63.6%)
CD8+: 295 (86.1%) 
WES with SCID and PID gene panel filter No No No >1.75 years Yes 
ITCL-12 Urgent CD3+: 1,090
CD4+: 790 (74.9%)
CD8+: 280 (83.9%) 
WES with SCID gene panel filter No No No >4 mo Yes 

ND, not determined.

a

First immunophenotyping results after referral from NBS.

b

Refers to immunological follow-up specifically.

or Create an Account

Close Modal
Close Modal

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Please sign in to your personal account to gift article access.

Register

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

Each link will stop working after 30 days or 10 uses. You may create up to 10 links in a 30 day period.

Gift articles remaining: --

Gift article access

As a benefit of your subscription, you can share temporary access to restricted articles.

Each link will stop working after 30 days or 10 uses.

You have reached the limit of 10 links within a 30 day period.